https://brixtonbio.com/news/ 2026-11-06T14:21:37+00:00 https://brixtonbio.com/brixton-biosciences-strengthens-executive-leadership-team-to-support-the-next-phase-of-company-growth/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/brixton-biosciences-strengthens-board-with-industry-veterans-as-company-advances-towards-commercialization-of-reneurx-tm-nerve-selective-therapy-for-pain-associated-with-knee-osteoarthritis/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/brixton-biosciences-announces-scientific-advisory-board-leadership/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/nih-grant/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/series-b/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/breakthrough-designation/ 2026-11-05T15:54:23+00:00 https://brixtonbio.com/brixton-biosciences-announces-pivotal-clinical-data-for-reneurx-nerve-selective-therapy-in-knee-osteoarthritis-to-be-presented-at-aahks-2026/ 2026-11-06T14:21:37+00:00